Literature DB >> 19837851

Differential expression of platelet-activating factor acetylhydrolase in lung macrophages.

Katherine M Howard1.   

Abstract

Platelet-activating factor (PAF) acetylhydrolase plays a crucial role inactivating the potent inflammatory mediator, PAF. PAF is implicated in the initiation and propagation of acute lung injury. Although PAF acetylhydrolase is a constitutively active plasma protein, increased PAF production during inflammatory events may necessitate an increase in PAF acetylhydrolase activity in the local environment. A series of experiments were conducted to determine whether the systemic administration of LPS to Sprague-Dawley rats resulted in enhanced expression of PAF acetylhydrolase in lung tissue. Ribonuclease protection assays revealed a dramatic increase in PAF acetylhydrolase mRNA, which peaked at 24 h following in vivo LPS administration. The increase in PAF acetylhydrolase mRNA was dose dependent and was detected when as little as 10 microg/kg of LPS was administered. Western blot analyses of lung tissue homogenates confirmed an increased production of PAF acetylhydrolase protein in response to LPS. In addition, Western blot analyses revealed the rat PAF acetylhydrolase protein exhibited heterogeneous molecular weights with predominant species migrating at 63 and 67 kDa. Some of the molecular weight heterogeneity likely resulted from extensive glycosylation of the secreted protein. Immunohistochemical analyses of lung tissue sections and colocalization experiments revealed a heterogenous population of cells that express the plasma-type PAF acetylhydrolase. Lung interstitial macrophages were PAF acetylhydrolase positive, but surprisingly, alveolar macrophages did not increase expression of PAF acetylhydrolase in response to systemic LPS administration. In addition, rat granulocytes consisting primarily of neutrophils were strongly positive for PAF acetylhydrolase in the LPS-exposed lung tissue. The absence of immunoreactive PAF acetylhydrolase in alveolar macrophages obtained from bronchial alveolar lavage confirmed that systemic LPS administration resulted in enhanced PAF acetylhydrolase expression only in a subset of lung macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837851      PMCID: PMC2793189          DOI: 10.1152/ajplung.00022.2009

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  49 in total

Review 1.  Cytokine down-regulation in endotoxin tolerance.

Authors:  M Mengozzi; P Ghezzi
Journal:  Eur Cytokine Netw       Date:  1993 Mar-Apr       Impact factor: 2.737

2.  Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

Authors:  L W Tjoelker; C Wilder; C Eberhardt; D M Stafforini; G Dietsch; B Schimpf; S Hooper; H Le Trong; L S Cousens; G A Zimmerman; Y Yamada; T M McIntyre; S M Prescott; P W Gray
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

3.  Release of platelet-activating factor in systemic lupus erythematosus.

Authors:  C Tetta; F Bussolino; V Modena; G Montrucchio; G Segoloni; G Pescarmona; G Camussi
Journal:  Int Arch Allergy Appl Immunol       Date:  1990

4.  Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.

Authors:  G Ambrosio; A Oriente; C Napoli; G Palumbo; P Chiariello; G Marone; M Condorelli; M Chiariello; M Triggiani
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

5.  Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase.

Authors:  M Furukawa; E L Lee; J M Johnston
Journal:  Pediatr Res       Date:  1993-08       Impact factor: 3.756

6.  Molecular cloning and expression of platelet-activating factor receptor from human leukocytes.

Authors:  M Nakamura; Z Honda; T Izumi; C Sakanaka; H Mutoh; M Minami; H Bito; Y Seyama; T Matsumoto; M Noma
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

7.  Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation.

Authors:  C J Meade; F Birke; S Metcalfe; C Watson; N Jamieson; G Neild
Journal:  J Lipid Mediat Cell Signal       Date:  1994-05

8.  Effect of a cigarette smoke extract on the metabolism of the proinflammatory autacoid, platelet-activating factor.

Authors:  S Miyaura; H Eguchi; J M Johnston
Journal:  Circ Res       Date:  1992-02       Impact factor: 17.367

9.  A comparative study of endothelin- and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells.

Authors:  C R Gandhi; K Stephenson; M S Olson
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

10.  Platelet-activating factor potentiates protamine-induced lung edema. Role of eicosanoids.

Authors:  C R Chen; N F Voelkel; S W Chang
Journal:  Am J Respir Crit Care Med       Date:  1994-01       Impact factor: 21.405

View more
  3 in total

1.  The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice.

Authors:  Zhilong Jiang; Melane L Fehrenbach; Giulia Ravaioli; Blerina Kokalari; Imre G Redai; Steven A Sheardown; Stephen Wilson; Colin Macphee; Angela Haczku
Journal:  Respir Res       Date:  2012-11-12

2.  Hydroxysafflor Yellow A Suppresses Platelet Activating Factor-Induced Activation of Human Small Airway Epithelial Cells.

Authors:  Xinjing Guo; Meng Zheng; Ruiyan Pan; Baoxia Zang; Ming Jin
Journal:  Front Pharmacol       Date:  2018-08-03       Impact factor: 5.810

3.  Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis.

Authors:  Mingming Deng; Yan Yin; Qin Zhang; Xiaoming Zhou; Gang Hou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.